Physician profile
Tamara E Coates
NPI 1740261338
$6,293.11
in general payments reported to CMS, 2019-2025
35 companies · $586 in 2025
The $586 reported for 2025 was more than what 84% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $623 · 2020: $393 · 2021: $969 · 2022: $2,094 · 2023: $1,178 · 2024: $452 · 2025: $586.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,215.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,215.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Scynexis, INC. | $1,142.33 | 2022 | |
| Daiichi Sankyo INC. | $774.36 | 2019-2025 | Injectafer |
| Abbvie INC. | $760.51 | 2019-2025 | Lo Loestrin Fe, Orilissa |
| Pfizer INC. | $440.83 | 2021-2025 | |
| Therapeuticsmd, INC. | $426.98 | 2019-2022 | |
| Sumitomo Pharma America, INC. | $374.51 | 2023-2025 | Myfembree, Gemtesa |
| Shield Therapeutics INC | $260.09 | 2023-2025 | Accrufer |
| Astellas Pharma US INC | $236.27 | 2023-2025 | Veozah |
| Aspira Women'S Health INC | $233.70 | 2021-2023 | Ova1 |
| Lupin INC. | $162.31 | 2019-2020 | |
| Millicent US INC | $138.07 | 2019-2025 | Intrarosa, Femring, Femlyv |
| Bayer Healthcare Pharmaceuticals INC. | $133.75 | 2019-2023 | |
| Baxter Healthcare | $125.20 | 2023 | Floseal, Tisseel |
| Hologic Sales and Service, LLC | $113.30 | 2023-2025 | Aptima, Novasure, Myosure Tissue Removal Device |
| Merck Sharp & Dohme LLC | $99.79 | 2021-2025 | Gardasil 9, Lynparza, Keytruda |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Avion Pharmaceuticals | $98.97 | 2019-2023 | Balcoltra |
| Myovant Sciences INC. | $96.06 | 2021-2022 | |
| Evofem Biosciences, INC. | $82.76 | 2022-2023 | Phexxi |
| Coopersurgical, INC. | $82.21 | 2020-2023 | Advincula Delineator Uterine Manipulator, Paragard T 380a |
| Mayne Pharma Commercial LLC | $58.91 | 2021-2023 | |
| Exeltis, USA INC. | $57.03 | 2023-2024 | Slynd |
| Clovis Oncology, INC. | $46.69 | 2019-2020 | |
| Sage Therapeutics, LLC | $45.36 | 2022-2024 | |
| Amgen INC. | $40.44 | 2022 | |
| Organon LLC | $35.44 | 2024-2025 | Nexplanon |
| Gilead Sciences, INC. | $34.65 | 2025 | |
| Mission Pharmacal Company | $29.77 | 2019 | |
| Ethicon US, LLC | $24.59 | 2025 | Vistaseal, Surgiflo Hemostatic Matrix, Stratafix |
| Duchesnay USA Incorporated | $24.42 | 2019 | |
| Cumberland Pharmaceuticals, INC. | $23.15 | 2021 | |
| Minerva Surgical, INC | $21.74 | 2020 | |
| Trevena, INC. | $21.23 | 2023 | Olinvyk |
| Davol INC. | $17.71 | 2021 | |
| Meditrina | $15.34 | 2022 | |
| Agile Therapeutics, INC. | $14.64 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tamara Coates listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.